Canada rejects 300,000 doses of the J.&J. vaccine made in the U.S. because of contamination issues. | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

Canada rejects 300,000 doses of the J.&J. vaccine made in the U.S. because of contamination issues.

Canada’s health products regulator has rejected the country’s first and only shipment of Johnson & Johnson’s Covid vaccine because of contamination issues at the U.S. plant that produced it.

The 300,000 doses had been held in storage since April to allow Health Canada to conduct a safety review. The regulator, in a statement issued on Friday evening, said that Emergent BioSolutions had made those doses at the same time as other batches of the Johnson & Johnson vaccine that were found to be contaminated with the harmless virus used to manufacture the AstraZeneca vaccine.

Health Canada said its review was unable to determine that the vaccines sent to Canada met “the department’s rigorous quality standards.” The regulator also said that it would not approve the use of any vaccines or vaccine ingredients made at the factory until it sends inspectors there, most likely in the summer.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA